ProPhase Labs, Inc. Prepaid Expense, Current
ProPhase Labs, Inc. (PRPH) had Prepaid Expense, Current of $143.00 thousand as of 2017-12-31, per its 10-K/A filed 2018-08-20.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2018-08-20
- 2017-12-31: Prepaid Expense, Current $143.00K.
- 2017-09-30: Prepaid Expense, Current $10.00K.
- 2017-06-30: Prepaid Expense, Current $17.00K.
- 2017-03-31: Prepaid Expense, Current $27.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2017-12-31 | $143.00K 10-K/A · filed 2018-08-20 |
| 2017-09-30 | $10.00K 10-Q/A · filed 2018-08-20 |
| 2017-06-30 | $17.00K 10-Q/A · filed 2018-08-20 |
| 2017-03-31 | $27.00K 10-Q/A · filed 2018-08-20 |
| 2016-12-31 | $263.00K 10-Q/A · filed 2018-08-20 |
| 2016-09-30 | $406.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $149.00K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $120.00K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $854.00K 10-K · filed 2017-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |